Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-02-23 @ 12:21 PM
Study NCT ID:
NCT03148860
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2017-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA
Sponsor:
Dr. Frank Behrens
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-21
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-04
First Submit QC Date:
None
Study First Post Date:
2017-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-01
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL